Leveraging engineered minicells for bioconversion of organic acids into short-chain methyl ketones

Ekaterina Kozaeva,Manuel Nieto-Domínguez,Kent Kang Yong Tang,Pablo Iván Nikel
DOI: https://doi.org/10.1101/2024.01.06.574483
2024-01-06
Abstract:Methyl ketones, key building-blocks widely used in diverse industrial applications, largely depend on oil-derived chemical methods for their production. Here, we investigated bio-based production alternatives for short-chain ketones, adapting the solvent-tolerant soil bacterium as a host for ketone biosynthesis either by whole-cell biocatalysis or using engineered minicells, chromosome-free bacterial vesicles. Organic acids (acetate, propanoate and butyrate) were selected as the main carbon substrate to drive the biosynthesis of acetone, 2-butanone and 2-pentanone. Pathway optimization identified efficient enzyme variants from and , which were tested under both constitutive and inducible expression of the cognate genes. By implementing these optimized pathways in . minicells, which can be prepared through a simple 3-step purification protocol, the feedstock was converted into the target short-chain methyl ketones, remaining catalytically functional for >4 months. These results highlight the value of combining morphology and pathway engineering of non-canonical bacterial hosts to establish alternative bioprocesses for toxic chemicals that are difficult to produce by conventional approaches.
Synthetic Biology
What problem does this paper attempt to address?